Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (OP: POLBF ) 0.1510 UNCHANGED Last Price Updated: 11:36 AM EDT, Sep 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.1510 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.1510 Today's Range 0.1510 - 0.1510 52wk Range 0.1070 - 0.2269 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market July 25, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces Change of Registered Address July 01, 2024 Via ACCESSWIRE Performance YTD +41.12% +41.12% 1 Month N/A N/A 3 Month N/A N/A 6 Month +37.27% +37.27% 1 Year +41.12% +41.12% More News Read More Poolbeg Pharma PLC Announces Annual Report & AGM Notice May 08, 2024 Via ACCESSWIRE Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office May 08, 2024 Via News Direct Topics Intellectual Property Exposures Intellectual Property Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office May 08, 2024 Via TheNewswire.com Topics Intellectual Property Exposures Intellectual Property Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA April 30, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023 April 29, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate April 29, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces TR-1: Notification of Major Holdings April 28, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces Appointment of Joint Broker April 29, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces POLB 001 US Patent Update March 19, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces Director Share Purchase February 19, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces POLB 001 Data Presented at ASH December 11, 2023 Via ACCESSWIRE Poolbeg Pharma PLC Announces Directorate Change November 30, 2023 Via ACCESSWIRE Poolbeg Pharma PLC Announces Immunomodulator II Patent Granted in Japan November 21, 2023 Via ACCESSWIRE Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented at IUIS November 16, 2023 Via ACCESSWIRE Former Amryt Pharma Leadership Team join Poolbeg November 09, 2023 Via ACCESSWIRE Poolbeg Pharma PLC Announces POLB 001 Data to be Presented at American Society of Hematology Annual Meeting November 03, 2023 Via ACCESSWIRE Poolbeg Pharma PLC Announces Board Role Change and Launch of EIP February 14, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRS February 11, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRS January 16, 2024 Via ACCESSWIRE Poolbeg Pharma PLC Announces RSV AI Drug Candidate Analysis Update December 19, 2023 Via ACCESSWIRE Poolbeg Pharma PLC Announces POLB 001 Oncology Programme Update Meeting November 01, 2023 Via ACCESSWIRE Poolbeg Pharma unveils new collaboration agreement October 18, 2023 Via News Direct Poolbeg Pharma unveils new collaboration agreement October 18, 2023 Via TheNewswire.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.